Dr. Wigley has an ongoing study of cytoxan for scleroderma lung involvement. You need to call Dr. Wigley at the Johns Hopkins Scleroderma Center and it may be worth a trip back to Baltimore for a re-evaluation.
A Small Favor
More than 15 years ago the Arthritis Center launched this website with the mission to bring current and accurate disease education to health care professionals and patients alike. Content on our site is generated directly by our team members. Unlike many health education websites we do not accept advertising, paid guests posts or charge for access to our site.
That’s where you come in. Your support will allow us to continue to deliver this valuable information to over 1 million visitors each year.Contribute TodayMore Ways to Give